No data available for drug.
Dosing & Uses
Drug Interaction
Adverse Reaction
Actions and Spectrum
Black Box Warning
Contraindication / Caution
Pregnancy / Lactation
Pharmacology
Administration
Patient Information Leaflet
DRUG INTERACTION
No drug interaction found for levosalbutamol and .
Contraindicated
levalbuterol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
acebutolol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
nebivolol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
penbutolol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
pindolol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Serious Use Alternative
isoprenaline
may increase the adverse effect of other beta2-agonists
albuterol
may increase the adverse effect of other beta2-agonists
indacaterol
may increase the adverse effect of other beta2-agonists
levosalbutamol
may increase the adverse effect of other beta2-agonists
olodaterol
may increase the adverse effect of other beta2-agonists
phenobarbital
levosalbutamol: they may increase the CNS depressant effect of CNS Depressants
apomorphine
levosalbutamol: they may increase the CNS depressant effect of CNS Depressants
flurazepam
levosalbutamol: they may increase the CNS depressant effect of CNS Depressants
perphenazine
levosalbutamol: they may increase the CNS depressant effect of CNS Depressants
neostigmine
levosalbutamol: they may decrease the therapeutic effect of anticholinesterases
isoflurophate
levosalbutamol: they may decrease the therapeutic effect of anticholinesterases
memantine/donepezil
levosalbutamol: they may decrease the therapeutic effect of anticholinesterases
donepezil (Rx)
levosalbutamol: they may decrease the therapeutic effect of anticholinesterases
isoprenaline
may increase the adverse effect of other beta2-agonists
albuterol
may increase the adverse effect of other beta2-agonists
indacaterol
may increase the adverse effect of other beta2-agonists
levosalbutamol
may increase the adverse effect of other beta2-agonists
olodaterol
may increase the adverse effect of other beta2-agonists
labetalol
may decrease the bronchodilatory effect of beta2-agonists
labetalol
may decrease the bronchodilatory effect of beta2-agonists
levalbuterol
may decrease the bronchodilatory effect when combined with beta2-agonists
acebutolol
may decrease the bronchodilatory effect when combined with beta2-agonists
penbutolol
may decrease the bronchodilatory effect when combined with beta2-agonists
pindolol
may decrease the bronchodilatory effect when combined with beta2-agonists
propranolol
may decrease the bronchodilatory effect when combined with beta2-agonists
Monitor Closely
hydrochlorothiazide
Beta2-Agonists: they mayincrease the hypokalemic effect when combined with thiazides
metolazone
Beta2-Agonists: they mayincrease the hypokalemic effect when combined with thiazides
quinethazone
Beta2-Agonists: they mayincrease the hypokalemic effect when combined with thiazides
trichlormethiazide
Beta2-Agonists: they mayincrease the hypokalemic effect when combined with thiazides
ethacrynic acid
Beta2-Agonists: they may increase the hypokalemic effect of loop diuretics
bumetanide
Beta2-Agonists: they may increase the hypokalemic effect of loop diuretics
muzolimine
Beta2-Agonists: they may increase the hypokalemic effect of loop diuretics
acebutolol
may decrease the bronchodilatory effect of beta blockers
atomoxetine
may have an increased tachycardic effect when combined with beta2-agonists
atosiban
atosiban: they may increase the toxic effect of Beta2-Agonists
theophylline
theophylline derivatives: they may increase the toxic effect of Beta2-Agonists
tranylcypromine
may have an increasingly adverse effect when combined with beta2-agonists
isocarboxazid
may have an increasingly adverse effect when combined with beta2-agonists
safinamide
may have an increasingly adverse effect when combined with beta2-agonists
selegiline
may have an increasingly adverse effect when combined with beta2-agonists
phenelzine
may have an increasingly adverse effect when combined with beta2-agonists
Minor
No data available for drug.
Dosing & Uses
Adult
Pediatric
Geriatric
Drug Interaction
DRUG INTERACTION
levosalbutamol
&
No Drug Intearction Found. for levosalbutamol and .
Contraindicated
levalbuterol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
acebutolol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
nebivolol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
penbutolol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
pindolol
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Serious Use Alternative
isoprenaline
may increase the adverse effect of other beta2-agonists
albuterol
may increase the adverse effect of other beta2-agonists
indacaterol
may increase the adverse effect of other beta2-agonists
levosalbutamol
may increase the adverse effect of other beta2-agonists
olodaterol
may increase the adverse effect of other beta2-agonists
phenobarbital
levosalbutamol: they may increase the CNS depressant effect of CNS Depressants
apomorphine
levosalbutamol: they may increase the CNS depressant effect of CNS Depressants
flurazepam
levosalbutamol: they may increase the CNS depressant effect of CNS Depressants
perphenazine
levosalbutamol: they may increase the CNS depressant effect of CNS Depressants
neostigmine
levosalbutamol: they may decrease the therapeutic effect of anticholinesterases
isoflurophate
levosalbutamol: they may decrease the therapeutic effect of anticholinesterases
memantine/donepezil
levosalbutamol: they may decrease the therapeutic effect of anticholinesterases
donepezil (Rx)
levosalbutamol: they may decrease the therapeutic effect of anticholinesterases
isoprenaline
may increase the adverse effect of other beta2-agonists
albuterol
may increase the adverse effect of other beta2-agonists
indacaterol
may increase the adverse effect of other beta2-agonists
levosalbutamol
may increase the adverse effect of other beta2-agonists
olodaterol
may increase the adverse effect of other beta2-agonists
labetalol
may decrease the bronchodilatory effect of beta2-agonists
labetalol
may decrease the bronchodilatory effect of beta2-agonists
levalbuterol
may decrease the bronchodilatory effect when combined with beta2-agonists
acebutolol
may decrease the bronchodilatory effect when combined with beta2-agonists
penbutolol
may decrease the bronchodilatory effect when combined with beta2-agonists
pindolol
may decrease the bronchodilatory effect when combined with beta2-agonists
propranolol
may decrease the bronchodilatory effect when combined with beta2-agonists
Monitor Closely
hydrochlorothiazide
Beta2-Agonists: they mayincrease the hypokalemic effect when combined with thiazides
metolazone
Beta2-Agonists: they mayincrease the hypokalemic effect when combined with thiazides
quinethazone
Beta2-Agonists: they mayincrease the hypokalemic effect when combined with thiazides
trichlormethiazide
Beta2-Agonists: they mayincrease the hypokalemic effect when combined with thiazides
ethacrynic acid
Beta2-Agonists: they may increase the hypokalemic effect of loop diuretics
bumetanide
Beta2-Agonists: they may increase the hypokalemic effect of loop diuretics
muzolimine
Beta2-Agonists: they may increase the hypokalemic effect of loop diuretics
acebutolol
may decrease the bronchodilatory effect of beta blockers
atomoxetine
may have an increased tachycardic effect when combined with beta2-agonists
atosiban
atosiban: they may increase the toxic effect of Beta2-Agonists
theophylline
theophylline derivatives: they may increase the toxic effect of Beta2-Agonists
tranylcypromine
may have an increasingly adverse effect when combined with beta2-agonists
isocarboxazid
may have an increasingly adverse effect when combined with beta2-agonists
safinamide
may have an increasingly adverse effect when combined with beta2-agonists
selegiline
may have an increasingly adverse effect when combined with beta2-agonists
phenelzine
may have an increasingly adverse effect when combined with beta2-agonists
Minor
Actions and Spectrum
Adverse Reaction
Black Box Warning
Contraindication / Caution
Pregnancy / Lactation
Pharmacology
Administration
Patient Information Leaflet
medtigo
Action and Spectrum
Drug Interaction
Adverse Reaction
Black Box Warning
Contraindication / Caution
Pregnancy / Lactation
Pharmacology
Adminstartion
Patient Information Leaflet